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EDITORIAL
Host response in urinary tract infections
Infections of the urinary tract have been studied
extensively in man and in experimental animals since
Kass first introduced the concept of quantitative
bacteriological examination of the urine [1]. This
procedure has allowed the ready identification of
patients with significant bacterial growth in the urinary
tract and has been used to explore the relationship of
bacteriuria to the development of chronic pyelone-
phritis. Bacteriuria in the female is common with
infections of the urinary tract accounting for 1.8% of
all new consultations in a survey of general practice in
New Zealand, compared with 0.2% for all other
diseases of the kidney (D. J. A. Gallagher, personal
communication, 1973). In contrast to this high mor-
bidity from infections of the urinary tract, terminal
renal failure from chronic pyelonephritis is not com-
mon [2, 3] and the relationship of this condition to
bacterial invasion of the kidney has been seriously
questioned [4]. The frequency of bacterial invasion of
the kidney [5—7] and the relative infrequency of signifi-
cant pathologic lesions in the kidney is a reflection of
the host's response to infection which will be examined
in detail in this review.
Bacterial invasion of the urinary tract. Bacteria enter
the bladder through the short female urethra despite
its high pressure zone [8] and the presence of urethral
mucus [9]. There is evidence that bacteria can pass up
the female urethra during micturition [10] and that
sexual activity may be a significant contributing
factor [11]. The male bladder, on the other hand, is
protected not only by the length of the urethra but also
by the bactericidal properties of prostatic fluid which
is capable of killing most strains of bacteria within six
hours both in the dog and in man [12]. The close
relationship between introital and vulval bacteria and
the presence of the same strains of bacteria in the
urinary tract [13—15] of the female provides further
evidence for the portal of entry of bacteria and an
explanation for the high incidence of urinary infection
in the female compared with the male. The bladder is
likely to be infected frequently but because of an
efficient host defense system eradication of bacteria
© 1974, by the International Society of Nephrology.
179
occurs in most instances. The spontaneous cure of one-
third of the patients with asymptomatic bacteriuria
[16] and the remarkable ability of the healthy bladder
to expel and destroy bacteria introduced into urine in
the bladder [17] illustrate the effectiveness of this
mechanism.
Host defenses in the lower urinary tract. The kinetics
of the mechanical removal of bacteria from the
urinary tract have been studied in vitro [18] and in
vivo [19] and show the importance of complete
emptying of the bladder in the elimination of bacteria
from the urinary tract. Once infection is established, a
residual urinary volume as small as 10 ml makes
elimination of bacteria from the bladder less efficient
[20].
Contrary to the generally held view, urine is not a
good culture medium, and several characteristics of
freshly voided urine, such as a comparatively low pH
and an osmolality that is above optimal for growth,
serve to restrict bacterial growth [21, 22]. Urinary urea
in high concentrations is inhibiting to bacterial growth
[23] and a high protein diet has been shown to reduce
bacterial growth in the renal medulla and cortex of
rats with enterococcal pyelonephritis [24]. In man, a
high protein diet results in concentrated urine with a
high urea content which has been shown to be a less
effective culture medium.
The bladder wall, too, has been shown to have
considerable bactericidal activity and bacteria in con-
tact with the wall are rapidly destroyed [25]. The precise
mechanism of this bactericidal effect has not finally
been elucidated, although one study indicated that
bacteria were killed by phagocytosis by polymorpho-
nuclear leucocytes [26].
When bacteriuria is established in the bladder, the
vesicoureteric valve and the ureter present further
mechanical barriers to the spread of infection, in
experimental studies it has been found that ascending
infection can be established with relative ease in the
rat compared with most animal species. The rat lacks
an effective vesicoureteric valve and reflux can be
shown to occur at each normal voiding [27]. In dogs,
infection is uncommon even when intravesical injec-
tion of bacteria leads to the induction of vesicoureteric
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reflux; therefore, other factors may also be involved
[28]. In vitro and in vivo studies have shown that
ureteric smooth muscle contractibility is affected by
common pathogens [29, 30] and Tsuchida, Hiroatsu
and Shigeru [31] have suggested on the basis of
experiments on dogs that both vesicoureteric reflux
and abnormal ureteric peristalsis are necessary con-
ditions for renal infection to become established.
Recent studies have shown that the ureter has an
intrinsic nerve supply [32, 33] which controls local
peristalsis and that destruction of the nerves may be
associated with ureteric atony and dilatation [34].
Application of these experimental procedures to a
study of ascending infection may resolve the role of
ureteric function in preventing tipper urinary tract
invasion.
Limitations of human studies. Evidence has been
sought from studies of patients for relevant host
responses to urinary tract infection and the principal
problem has been to determine the site of infection.
This has been established with a reasonable degree of
accuracy using either ureteric catherization [35] or
bladder irrigation procedures [361. These studies have
shown that bacteria are present in one or the other
ureter of one-half of the patients presenting with
urinary tract infections in the community [6]. How-
ever, it has not been practical, apart from isolated
studies in small groups of patients [37], to correlate
the associated histopathologic changes in the kidney
with bacteriologic information obtained during indivi-
dual episodes of infection, nor with the natural history
of recurrent urinary tract infection.
Earlier reports suggesting a close correlation be-
tween the serum antibody titer and bacterial involve-
ment of the renal parenchyma [38] have not been con-
firmed by recent studies using localization procedures
[6]. The determination of serum antibody titers against
homologous bacteria may, however, be useful in
identifying groups of patients with upper urinary
tract infection, although the method is not sufficiently
specific for the assessment of the individual patient. An
explanation for the poor correlation between serum
antibody titer and the bacteriologic status of the kidney
was provided by recent animal studies where it was
found that the eradication of infection, or even sur-
gical removal of the infected kidney, did not affect the
titer of circulating antibody [39, 40]. Thus, while an
immune response is a component of the host's res-
ponse to urinary tract infection, the subsequent course
of infection is not reflected by the concentration of
serum antibody.
Indirect evidence of kidney involvement depending
on a reduced concentrating capacity has also been used
to identify infected kidneys. Ronald, Cutler and Turck
showed in man that renal concentrating capacity was
impaired to a greater extent in the infected kidney than
the contralateral uninfected organ [41]. This defect in
concentrating capacity was interpreted as implying
bacterial involvement of the medullary region of the
kidney but could also have been due to reversible
edema from inflammatory changes in the renal pelvis
rather than invasion of the renal parenchyma.
f-lost response in experimental models. Because of
the limitations of human studies, experimental studies
in the rat, rabbit and dog have been used to investigate
the host response to urinary tract infection. A variety
of procedures have been used to induce renal infection
in animals, most of which involve either ureteric
obstruction or trauma to the kidney. We have used a
method in which bacteria are introduced directly into
the kidney through a glass micropipette under direct
vision. Although induction of infection is almost
certainly due to the dual effects of local trauma and
bacterial lodgement, the clinical and bacteriologic
course of the disease parallels many aspects of the
disease in man [42]. The model has many advantages,
not the least being that the pathologic changes
including scarring, lymphocytic infiltrate, colloid casts
and interstitial fibrosis, features which lack specificity
in human disease, are associated directly with an
infectious process. Several remarkable features of the
experimental infection are peculiar to renal infections
and mimic closely the clinical problem. First, despite
the resistance of the intact unobstructed kidney to
infection, an active infection may be established after
minimal intrarenal trauma by a small number of
bacteria which would be incapable of establishing in-
fection in most other tissues. Furthermore, bacteria
which are readily cleared within hours from sites such
as blood, liver, spleen and muscle, once introduced
into the kidney, establish an active infection which
persists for long periods and may never be eliminated
during the lifetime of the animal [39]. There is also
little evidence for progressive loss of renal function
in these animals, despite continuing infection. Where
untreated animals have been followed for up to six
weeks after infection, renal function, although de-
pressed initially, has returned to normal [43].
Intrarenal response to infection. One widespread
belief that has influenced the investigation of host
defense mechanisms is that the renal medulla is
unusually susceptible to infection and is the site of
bacterial persistence in chronic infection. Phrases such
as the "unique susceptibility" and the "exquisite
sensitivity" of the medulla to infection appear in the
literature on pyelonephritis, but are inconsistent with
much experimental evidence.
One mechanism that has been proposed to explain
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the apparent susceptibility of the medulla to infection
is that the hypertonic region of the medulla causes a
delayed granulocytic response that allows infection to
become established in the medulla [44]. However,
subsequent events involving the spread of infection
beyond the original lesion show that mobilization of
phagocytic cells into adjacent infected but undamaged
tissue does not occur and that the polymorphonuclear
infiltrate remains confined to the initial inflammatory
foci. Thus, the short delay in the appearance of phago-
cytic cells in the inflammatory thermal lesion of the
medulla compared to cortex is probably not an impor-
tant feature in the establishment of infection. A more
important defect may be the poor chemotactic capacity
of Escherichia coli, both in the cortex and in the
medulla, resulting in an ablated rather than a delayed
phagocytic cell response. Evidence of neutrophilic
exudation being mediated through the complement
system [45] which is inactivated by renal tissue [46] is
consistent with the deficient response to infection of
the phagocytic cell.
Bacterial persistence has been investigated experi-
mentally in the rat kidney where the vascular cortical
tissue can readily be differentiated macroscopically
from the medulla and from the papilla. When care is
taken to separate cortex from the medulla, there is no
suggestion that bacteria either proliferate preferen-
tially in medullary tissue or persist in that region; the
consistent increase in bacteria in the papilla may simply
represent concentration of luminal bacteria [47].
Although the mobilization of polymorphonuclear
leucocytes during renal infection has been studied, the
function of other inflammatory cells forming the inter-
stitial infiltrate have not been well characterized,
although the morphological details have been known
for many years. Components of the host's defense in
the kidney are likely to include nonspecific phago-
cytosis, cell-mediated immune responses and specific
antibody production. In both acute and chronic renal
infection the small lymphocyte has been found to be
the predominant inflammatory cell even when numer-
ous polymorphonuclear leucocytes are present in
luminal casts. There is ample evidence documenting the
movement of antibody-forming-cells into the infected
kidney [39, 48, 49] but the significance of these remain
to be defined. As yet, there is no evidence for a
significant cell mediated immune response in pyelone-
phritis although cellular immunity with macrophage
activation induced by stimulation of thymus-derived
lymphocytes has been described in several nonrenal
bacterial infections [50].
Significance of the specific immune response. In both
animals and man, infection of the urinary tract may
result in an increase in circulating antibody directed
against the invading organism [51, 52] although the
protective value of this response remains to be
established. As well as the systemic immune response
to infection a local immune response has been reported
in pyelonephritis [53] and in lower urinary tract infec-
tion [54]. IgG with antibacterial activity has been
found in the urine [55] and increased immunoglobulin
excretion in urinary tract infections has been reported
in both animal and human studies [56—58].
Local antibody synthesis has been shown to persist
for long periods following acute infections [59] and
clearly demonstrates that the kidney, a nonlymphoid
organ, is capable of local immunoglobulin synthesis
during the course of an infection. The specific nature
of the antibacterial antibody formed within the kidney
has been confirmed at a cellular level and the cellular
kinetics of the immune response have been established
[39, 48]. In these studies the persistence of antibody
forming cells in the pyelonephritic kidney was a fea-
ture of the immune response and suggested that con-
tinued local antibody synthesis may be an important
component of the host defense mechanism in urinary
tract infection. When immunoglobulin synthesis was
studied and related to mechanisms of host defense in
the lower urinary tract, however, no evidence of en-
hanced bacterial elimination was found [60].
Studies of autoimmune processes as a component of
the host's response to infection followed the clinical
observation that kidneys are frequently sterile in
chronic pyelonephritis [61]. That progression of the
lesion may not require the presence of viable bacteria
is supported by the report by Kovats [62] of altera-
tions in tissue antigenicity produced by endotoxin so
that antibody produced against "endotoxin modified
renal tissue" could result in further tissue damage.
Holmgren et a! [63] have found a common antigenic
determinant shared between E. coli and renal tissue
which may provide a basis for this local immunologic
reaction, particularly as complement fixing antibodies
are consistently found in renal infection [64]. Combina-
tion of circulating antibody with renal antigen either
modified by endotoxin or sharing common antigens
with E. coli could result in complement fixation and
subsequent renal damage. Studies to date have, how-
ever, failed to demonstrate antikidney antibody in
either patients or animals using a variety of techniques
[65, 66]. Absorption of circulating antibody by anti-
gen, as occurs in chronic glomerulonephritis, could
explain the negative findings, but even when locally
synthesized antibody was examined for antikidney
antibody no activity was found [67].
Alteration of the serum bactericidal ability has also
been investigated as an aberrant host defense mech-
anism leading to the establishment of renal infection.
182 Miller/North
Earlier work by Kalmanson, Hubert and Guze [68]
suggested that there might be a generalized decrease in
serum bactericidal activity in patients with urinary
tract infections but Kimball, Garcia and Petersdorf
[69] have implicated the invading organism by
suggesting that bacterial strains responsible for urinary
tract infections had increased resistance to normal
serum bactericidal activity. More recently Taylor [70]
has described an antibactericidal mechanism which
has been associated with infection of the upper urinary
tract [71] and which possibly acts as a blocking factor
preventing lysis of otherwise sensitive bacteria.
Complement-dependent bacteriolysis, however, is
probably not important, and in the final analysis the
decisive event determining whether a bacterial cell can
proliferate in a given environment remains whether
the organism can resist phagocytosis. The deficient
phagocytic cell response to renal infection has already
been mentioned and probably remains the dominant
factor in the host defense processes.
Acquiescent bacterial state. Although many host
factors have been examined experimentally in relation
to the establishment and persistence of infection, the
consistent and predictable pattern that emerges with
infection of an unobstructed kidney is that of an acute
inflammatory nonprogressive lesion which heals with
contraction and scarring, and in which bacteria may
persist despite an adequate host immune response.
This situation is not uncommon in infectious diseases
where the organisms are protected from the host's
defense mechanism because of their intracellular
location. The long-term relationship between the host
and the invading organism in chronic renal infections,
however, has not been examined in detail despite its
obvious importance.
Our current views of the host-parasite relationship
in urinary tract infections have been influenced by
studies of infections in the rat, where pyelonephritis
has been Induced unilaterally following direct inocu-
lation of bacteria into one kidney only. The subsequent
bacteriologic, immunologic and pathologic changes
have then been followed in the contralateral, unmanip-
ulated kidney as well as in the pyelonephritic kidney.
Using this model it has been possible to investigate the
relationship of the invading organism to the host and
the association between the presence of viable bacteria
in the kidney and the development of pathologic
lesions [72].
The most striking feature of this study was the lack
of correlation between bacterial growth and patho-
logic changes in the kidney (Table 1). In the damaged
kidney into which the bacteria had been injected,
scarred and contracted kidneys were found showing
the characteristic pathologic features of pyelone-
phritis. In the contralateral kidney, however, approx-
imately the same number of bacteria were present in
Table 1. Bacteriologic, histologic and gross changes in pyelonephritic and contralateral unmanipulated rat kidneys examined seven
months after the induction of infection with E. co/i 075
Bacteriologic
culture
No. No.
Histologic assessment
of renal damage
Gross changes
++++ +++ ++ + — ++++ +++ ++ + —
Infected Sterile
Pyelonephritic 14 2 2 4 7 2 1 5 9 1 1 0
kidney
Log. No. 5.40 4.39 5.75 5.04 0.00
Bacteria per 5.30 4.30 5.11 4.64
gram of kidney 4.26 4.75
tissue 4.25 4.66
4.11
4.07
0.00
Contralateral 12 4 0 0 0 9 7 0 0 0 4 12
kidney
Log. No. 5.43 6.04
Bacteria per 5.11 4.41
gram of kidney 4.80 3.52
tissue 4.70
4.57
4.34
4.32
4.30
3.32
0.00
0.00
0.00
0.00
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the kidney but the pathologic changes were minimal.
When the distribution of bacteria within the uninjured
kidney was examined, organisms were found to be
present throughout the kidney and not simply con-
fined to the areas showing pathologic lesions (Fig. I).
It is evident then that while the kidney may be more
susceptible to infection under circumstances such as
recurrent reflux, it remains relatively resistant to the
induction of pathologic changes. The necessity to
differentiate infection from infection with patho-
logic changes is obvious; this must complicate the
interpretation of bacteriologic data obtained by
ureteric catheterization when information of histo-
logic response in the kidney is lacking.
Once infection is established in the urinary tract, it
appears that the host responds with a vigorous and
well characterized specific immune response. At first
inspection, the host response appears neither to con-
trol the infection nor to result in an extension of the
pathologic process. The host seems to have become
tolerant to a state of continuing infection in a normally
sterile tissue and is incapable of eliminating the
invading organism. As a result, E. co/i present in the
kidney in large numbers do not initiate pathologic
changes unless this balance is upset by local trauma,
obstruction, alterations to renal blood flow or one of
the many other host factors increasing susceptibility
to infection that have been studied [73, 74]. The term
"tolerance" has a well established immunologic
meaning and we prefer to use the term "acquiescent
infection" to describe the host-parasite relationship in
this situation where the balance is maintained between
the host and invading organism, usually without local
pathologic lesions.
Some support for an "acquiescent state" in renal
infection in man can be found in the literature.
Fairley et al [6], in an investigation of the site of acute
urinary tract infection in general practice, found a
good correlation between serum antibody and the site
of infection, which may have reflected the minor
degree of pathologic damage in individuals who dis-
played no rise in serum antibody titer. Glynn, Brumfitt
and Howard [75], also on the basis of localization
studies, suggested that ureteric bacteriuria might not
always represent pathologic changes and Gower et al
[71] has discussed evidence that bacteria might reside
in the upper urinary tract without producing renal
damage.
Possible role of enhancing antibody. In an attempt to
explain the biological basis for an acquiescent state in
urinary tract infections, we have re-examined the role
of the specific immune response in host defense
mechanisms. One possibility is that the invading
organism may, in fact, be utilizingthe immune response
to induce an acquiescent state and so escape host
defense mechanisms. This pathogenic mechanism of
immunologic enhancement has been well characterized
both experimentally [76] and in human studies in the
field of tumor immunology [77]. In essence, the tumor
implant is protected from the host's cell-mediated
defense mechanism by circulating enhancing antibody,
and thus proliferates unchecked. The phenomenon is
not confined to tumor immunobiology and has been
observed in renal allografts in animals [78] and man
[79].
The idea has not been applied to microbial persis-
tence but is theoretically applicable to situations
where antibody production does not correlate with
protection and where bacteria persist in the presence of
an immune response. In applying the enhancing anti-
body phenomena to renal infection, we would suggest
that antibody produced during the immune response,
rather than being host-protective, may be immuno-
protective and so assist the persistence of invading
organisms. This possibility could be evaluated by
demonstrating a direct correlation between bacterial
persistence in the kidney and the comparative capacity
of the pathogen to stimulate antibody production.
Results from such experiments are not available from
the literature so we have approached the problem by
modifying the immune response of the host and
observing the effect of this modification on the
capacity of the invading organism to persist. In these
experiments cyclophosphamide was administered to
prevent the postulated capacity of the host to mount an
enhancing antibody response; cyclophosphamide,
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Fig. 1. Distribution of bacteria in the unmanipulated kidney.
Animals were sacrificed seven months after the induction of a
unilateral pyelonephritis. The contralateral kidneys were then
dissected into cortical, medullary and papillary tissue and the
bacterial numbers determined. Data are the average of 12
kidneys examined.
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Fig. 2. Effect of cyclophosphamide on the response of the rat to
renal infection. Pyelonephritis was induced in two groups of
animals, one of which received cyclophosphamide, 100 mg/kg,
in divided doses two and four days after bacterial challenge.
A, Effect of cyclophosphamide on the immune response. B, EJfrct
of cyclophosphamide administration on the number of bacteria in
the kidney 30 days after infection. These differences are signifi-
cant at the 99% confidence level (Wilcoxon sum of ranks
analysis).
according to this hypothesis, would enhance the
elimination of the invading organisms. The results
which are summarized in Fig. 2 show an inverse re-
lationship between the immunocompetence of the host
and the capacity of the host to clear bacteria from an
infected kidney. The antimicrobial effect of cyclo-
phosphamide administration remains to be investigated
as a possible explanation for these results, but in view
of the great difficulty experienced in eradicating
experimentally induced renal infections with prolonged
antibiotic therapy, it seems unlikely that this will be
the case. If these findings are confirmed, it may be
possible to manipulate host defense mechanisms to
counter the immunoprotective effect of specific anti-
body and restore the capacity of the host to eliminate
the invading organism.
Some idea of the complexity of the host response to
urinary tract infection and the difficulties facing both
the clinical and experimental investigator will be
apparent. Urinary tract infections are still a major
cause of morbidity in man, so that a critical under-
standing of the basic host-parasite relationship should
be a matter of concern to all nephrologists.
Thomas E. Miller
J. Derek K. North
Auckland, New Zealand
Reprint requests to Dr. J.D.K. North, Department of Medicine,
University of Auckland, Private Bag, Auckland, New Zealand.
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